8 Jul 2020 Covid-19 Infectious diseases Oncology Pharma & Biotech Research & Innovation Visit our Oncology expertise page Related News France's attractiveness Pharma & Biotech BIO-Europe Spring - the leading biotech get-together goes back to being an in-person event Pharma & Biotech Research & Innovation Servier and Gustave Roussy sign a framework agreement to collaborate in oncology and immuno-oncology Research & Innovation Advanced BioDesign receives €14.3 M from Xerys Invest to continue its ODYSSEY trial Next events 01 February 2023 - 30 November 2023 French Healthcare Booster 2023 – Germany Germany 15 February 2023 - 30 November 2023 French Healthcare Booster 2023 - Italy and Spain Italy and Spain 13 March 2023 - 31 October 2023 NEXT FRENCH HEALTHCARE Montreal, Boston
France's attractiveness Pharma & Biotech BIO-Europe Spring - the leading biotech get-together goes back to being an in-person event
Pharma & Biotech Research & Innovation Servier and Gustave Roussy sign a framework agreement to collaborate in oncology and immuno-oncology
Research & Innovation Advanced BioDesign receives €14.3 M from Xerys Invest to continue its ODYSSEY trial
